Patent · US Active

Metabolic engineering

US12391963B2 · kind B2 · utility

0Cited by
1References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2018
Grant dateAug 19, 2025
Priority date
Expiry dateNov 12, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y504/99039
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates generally to materials and methods for biosynthesising quillaic acid in a host by expressing heterologous nucleotide sequences in the host each of which encodes a polypeptide which in combination have said QA biosynthesis activity. Example polypeptides include (i) a Beta-amyrin synthase; (ii) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-28 position to a carboxylic acid; (iii) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-16α position to an alcohol; and (iv) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-23 position to an aldehyde. Preferred nucleotide sequences are obtained from, or derived from, Q. saponaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.